|Bid||101.98 x 800|
|Ask||103.03 x 800|
|Day's Range||102.32 - 104.41|
|52 Week Range||78.90 - 104.41|
|Beta (3Y Monthly)||0.64|
|PE Ratio (TTM)||35.80|
|Earnings Date||Jul 31, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||0.66 (0.64%)|
|1y Target Est||109.27|
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
Zoetis Inc. (ZTS) will participate in the Stifel 2019 Dental & Veterinary Conference on Wednesday, May 29, 2019, in New York, N.Y. Clint Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics will represent the company and respond to questions from analysts.
Zoetis held its annual meeting today in Short Hills, N.J., with Chairman Michael B. McCallister presiding over the business portion of the meeting and shareholder voting. Chief Executive Officer Juan Ramón Alaix discussed the company’s strong performance in 2018 and its strategies for continued growth and market leadership in the global animal health industry. Juan Ramón Alaix, Paul M. Bisaro, Frank A. D’Amelio and Michael B. McCallister have been elected as directors for three-year terms.
Zoetis Inc NYSE:ZTSView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for ZTS with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZTS. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $1.18 billion over the last one-month into ETFs that hold ZTS are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
The best pharmaceutical stocks to buy have commonalities: Strong Composite Ratings and Relative Strength Ratings.
Teva stock toppled Thursday after the generic drug behemoth's first-quarter report "gave no reason for confidence," according to one analyst. Meanwhile, Zoetis stock moved into buy range.
Zoetis (ZTS) delivered earnings and revenue surprises of 11.39% and -0.73%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Parsippany, New Jersey-based company said it had net income of 65 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 88 cents ...
Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Juan Alaix has been the CEO of Zoetis Inc. (NYSE:ZTS) since 2012. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other big companies. Next, we'll consider growth that t...
Zacks.com featured expert Kevin Matras highlights: Cadence Design System, CSX, Celanese and Zoetis
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
“At Zoetis, we know our people shape our reputation as a great place to work and drive our success,” said Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications. Forbes determined its America’s Best Employers list based on an independent survey among a sample of 50,000 American employees working for companies with at least 1,000 people in their U.S. operations.